Pharmacoepidemiological monitoring of the sale of antidiabetic drugs in the Volga Federal District

Introduction. Diabetes mellitus (DM) is a chronic non-infectious disease widespread in the Russian Federation, which has a significant impact on the health of the population and the budget of the health care system. For drug therapy of patients with DM, federal and regional programs of preferential drug provision are being implemented, however, a significant part of federal beneficiaries purchase drugs at the expense of personal funds. The purpose of the study is to study the features of the sale of antidiabetic drugs in the retail sector of the pharmaceutical market of the Volga Federal District. Material and methods. The objects of the study are the nomenclature of antidiabetic drugs sold in 16,554 pharmacy organizations of the Volga Federal District for the period from 2021 to 2024. The source of information is the AlphaRM database. Methods: pharmacoepidemiological, comparative, systemic, retrospective analyses, content analysis, grouping methods, descriptive statistics. Results. Pharmacoepidemiological analysis of retail sales of sugar-lowering drugs (SLP) in pharmacy organizations of the Volga Federal District in 2021-2024 was carried out. Conclusion. Features of population consumption of FMF were identified with a focus on retail sales of combination drugs.